ID3 and cancer: Overexpression of Id1 and Id3 has been correlated with an unfavorable prognosis in a variety of cancer types (11-13) and a recent study suggested Id1 and Id3 co-expression was related to poor clinical outcome in stage III-N2 non-small cell lung cancer (NSCLC) (14).